Specifically, overexpression of GCSFR has been identified in nasopharyngeal, oral cavity, breast, colorectal, and ovarian cancer cells with data suggesting a potential role for GCSFR in cancer progression (3–6). The gene discussed is CSF3R; the disease is ovarian cancer.